Express Scripts (ESRX): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Express Scripts ( ESRX) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 1.7%. By the end of trading, Express Scripts fell $1.46 (-2.2%) to $63.97 on average volume. Throughout the day, 3,501,628 shares of Express Scripts exchanged hands as compared to its average daily volume of 4,331,000 shares. The stock ranged in price between $63.93-$65.00 after having opened the day at $64.94 as compared to the previous trading day's close of $65.43. Other companies within the Health Care sector that declined today were: Pingtan Marine Enterprise ( PME), down 82.5%, Mast Therapeutics ( MSTX), down 43.8%, Cardium Therapeutics ( CXM), down 15.9% and MannKind Corporation ( MNKD), down 12.5%.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $53.6 billion and is part of the health services industry. Shares are up 21.1% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, Biolase ( BIOL), up 55.0%, Cormedix ( CRMD), up 27.8%, GW Pharmaceuticals PLC ADR ( GWPH), up 16.9% and Concord Medical Services Holdings ( CCM), up 14.8%.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Here's How to Invest Like a Billionaire

The Dow Binges on Earnings

Alphabet Slides After a So-So Quarter - 5 Things You Must Know Before the Market Opens